0.67
-0.0059(-0.87%)
Currency In USD
| Previous Close | 0.68 |
| Open | 0.67 |
| Day High | 0.68 |
| Day Low | 0.66 |
| 52-Week High | 1.91 |
| 52-Week Low | 0.64 |
| Volume | 101,571 |
| Average Volume | 2.99M |
| Market Cap | 13.93M |
| PE | -0.49 |
| EPS | -1.37 |
| Moving Average 50 Days | 0.76 |
| Moving Average 200 Days | 1.22 |
| Change | -0.01 |
If you invested $1000 in Envoy Medical, Inc. (COCH) since IPO date, it would be worth $68.6 as of December 31, 2025 at a share price of $0.67. Whereas If you bought $1000 worth of Envoy Medical, Inc. (COCH) shares 2 years ago, it would be worth $66.82 as of December 31, 2025 at a share price of $0.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
Newsfile
Dec 18, 2025 1:00 PM GMT
Enrollment momentum accelerates as Company advances toward full enrollmentWhite Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fu
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
Newsfile
Dec 16, 2025 1:00 PM GMT
Patent strengthens Company's global intellectual property portfolio and reinforces the Company's commitment to establishing and protecting competitive advantagesWhite Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical® Inc. (N
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
Newsfile
Dec 10, 2025 1:00 PM GMT
Momentum continues to build for Company as series of clinical milestones are met, design choices cement differentiation from competition, and timeline comes into focusWhite Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical® I